Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Highest usefulness score first. Studies without a score come last.
-
Neither work complexity (p = 0.995) nor work duration (p = 0.701) showed a significant effect on the likelihood of presenting a lower cognitive profile or developing dementia (p = 0.385 and p = 0.096, for work complexity and work duration, respectively).
-
54/100
There is both clinical and neuroanatomical variability at the single-subject level in Alzheimer's disease, complicating our understanding of brain-behaviour relationships and making it challenging to develop neuroimaging biomarkers to track disease severity, progression, and response to treatment.
-
54/100
Lower HDL-C was significantly associated with a higher odds of cognitive impairment (OR 2.70 per 1 mmol/L reduction; 95% CI 1.25, 5.56; p = 0.011), whereas BMI, TG, glucose and HbA1c were not (all p > 0.05).
-
Data were available from 131 participants with age ranging from 65.4 to 88.2 years and mean follow up of 2.4 years (SD = 1.0).
-
Among metabolic syndrome components, the effects of higher plasma glucose levels on cognitive decline (CD) have been considered in few studies.
-
The effects of exercise and physical activity on cognitive function and brain health have been established by longitudinal and intervention studies.
-
Whereas traumatic brain injury (TBI) results in widespread disruption of neural networks, changes in regional resting-state functional connectivity patterns after insult remain unclear.
-
This large study has provided additional robust evidence for the existence of neuropsychiatric subsyndromes in AD.
-
In this survey study, all types of objectively measured VI were associated with a higher dementia prevalence.
-
The SLS is a valid and reliable self-administered memory test that shows promise for remote assessment of aging and neurodegenerative disorders.
-
When validated with subjects diagnosed using an official test, the model achieves COVID-19 sensitivity of 98.5% with a specificity of 94.2% (AUC: 0.97).
-
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases.
-
53/100
In this prospective, population-based study the prevalence of iNPH was 3.7% among individuals 65 years and older, and more common in the higher age group, 80 years and above.
-
53/100
In Alzheimer's disease (AD), deposition of insoluble amyloid-β (Aβ) is followed by intracellular aggregation of tau in the neocortex and subsequent neuronal cell loss, synaptic loss, brain atrophy, and cognitive impairment.
-
Alzheimer's disease (AD) is an irreversible brain degenerative disorder affecting people aged older than 65 years.
-
Our study is a unique resource of neuroimaging and cognitive measures relevant to change across the adult lifespan.
-
53/100
Comorbid frontotemporal dementia is a negative prognostic indicator.
-
Frequency of participation in cognitively stimulating activities appears to be associated with risk of AD and may partially explain the association of educational and occupational attainment with disease risk.
-
Power analyses for voxels showing maximal decline over the 1-year period in regional cerebral glucose metabolism (mg/100 g per minute) were computed to estimate the sample sizes needed to detect a significant treatment response in a 1-year, double-blind, placebo-controlled treatment study.
-
Clinically diagnosed Alzheimer's disease and other dementing illnesses were assessed in a geographically defined US community.
-
52/100
Group comparisons revealed significantly decreased within-network connectivity in salience-ventral attention, cognitive control, and default mode network in participants with postoperative delirium (n=31) compared with non-delirious participants (n=89; non-parametric permutation test, 1000 iterations, P<0.05).
-
Cognitive reserve and frailty are factors associated with Alzheimer's disease and related dementias (ADRD).
-
Rs-fMRI analysis revealed significant associations between FC and MedDietScore.
-
The SCST total score, cognitive domain scores (attention, language, visuospatial function, memory, executive function), and most of the subtest scores decreased significantly in the order of SCD, MCI and dementia.
-
111 out of 287 participants had hearing impairment.
From across this topic
10 of the 1,533 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: The CABLE study
- Impact of Concurrent Visual and Hearing Impairment on Incident Alzheimer's Disease: The LIFE Study
- Speaker-Attributed Transcription Toward Automated Scoring of NACC Uniform Data Set Assessments: A Whisper–Pyannote Pipeline and Pilot Evaluation
- Convolutional neural networks for classification of Alzheimer's disease: Overview and reproducible evaluation
- Depression and dementia
- Brain Iron Accumulation and Its Cognitive and Olfactory Correlates in Late-Life Depression
- Arterial stiffness, cognitive impairment and dementia: confounding factor or real risk?
- Grey matter volume and CSF biomarkers predict neuropsychological subtypes of MCI
- Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment
- What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration